| Oct 4 |
Guardion Health Sciences Announces Delisting and New Interim CEO
|
| Aug 29 |
Peering Into Guardion Health Sciences's Recent Short Interest
|
| Aug 22 |
Guardion Health Sciences declares $5.00 dividend
|
| Aug 21 |
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
|
| Aug 16 |
Guardion Health Sciences Second Quarter 2024 Earnings: US$1.66 loss per share (vs US$0.93 loss in 2Q 2023)
|
| Aug 14 |
Guardion Health Sciences reports Q2 results
|
| Aug 13 |
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
|
| May 31 |
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
|
| May 23 |
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
|
| May 21 |
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024
|
